Lifeclean Q4’22: First take – roughly in line - Redeye

Redeye saw sales that almost reached our expectations for the quarter. Sales have recovered somewhat since a weak Q3. Opex was very much in line with expectations. PFAS interestingly a large part of the sales in the quarter.

Länk till analysen i sin helhet: https://www.redeye.se/research/878594/lifeclean-q422-first-take-roughly-in-line?utm_source=finwire&utm_medium=RSS